Icon

AZOPT (nda020816)- (1%)

BRINZOLAMIDE SANDOZ
1%
No No
2013-Apr-24 Expired
None None
None No
AZOPT is a carbonic anhydrase inhibitor indicated for in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma
3 0 3
Total Other Developers 30
Drugs with Suitability No
1% ** ** Down - 3
NDA Sales Available Total Generic Sales Available
Yes 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** *** **** ****** & **** ************ *********** **** ****** ***** *******, *****, ******* (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.